triazoles has been researched along with Ascites in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirakawa, H; Mizunuma, H; Yokoyama, Y; Yoshida, H | 1 |
| Garde-Granger, P; Lane, D; Laplante, C; Matte, I; Piché, A; Rancourt, C | 1 |
| Hu, X; Huang, K; Luo, Y; Mai, Q; Yang, G; Yuan, Y; Zhou, C | 1 |
| Chen, ZL; Cheng, JL; Gui, WJ; Jin, RY; Zhu, GN | 1 |
| Creutzfeldt, W; Fayyazzi, A; Leonhardt, U; Seidensticker, F; Söling, HD; Stöckmann, F | 1 |
| Canonico, A; Casini, G; Felici, M; Ferappi, M; Lucentini, P | 1 |
1 trial(s) available for triazoles and Ascites
| Article | Year |
|---|---|
Effect of letrozole on moderate and severe early-onset ovarian hyperstimulation syndrome in high-risk women: a prospective randomized trial.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aromatase Inhibitors; Ascites; Aspirin; Chorionic Gonadotropin; Estradiol; Female; Humans; Letrozole; Luteal Phase; Nitriles; Oocyte Retrieval; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Primary Prevention; Reproductive Control Agents; Risk Assessment; Severity of Illness Index; Triazoles; Vascular Endothelial Growth Factor A | 2017 |
5 other study(ies) available for triazoles and Ascites
| Article | Year |
|---|---|
Inhibitory effects of aromatase inhibitor on estrogen receptor-alpha positive ovarian cancer in mice.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents, Hormonal; Apoptosis; Aromatase; Aromatase Inhibitors; Ascites; Cell Line, Tumor; Estrogen Receptor alpha; Female; Forkhead Transcription Factors; Humans; Letrozole; Mice, Inbred BALB C; Mice, Nude; Neovascularization, Pathologic; Nitriles; Ovarian Neoplasms; Ovariectomy; Peritoneal Neoplasms; Repressor Proteins; Signal Transduction; Time Factors; Triazoles; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2014 |
Ovarian cancer ascites enhance the migration of patient-derived peritoneal mesothelial cells via cMet pathway through HGF-dependent and -independent mechanisms.
Topics: Ascites; Cell Movement; Cells, Cultured; Cytokines; Enzyme Activation; Epithelial Cells; ErbB Receptors; Female; Hepatocyte Growth Factor; Humans; Immunoblotting; Inflammation Mediators; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Ovarian Neoplasms; Peritoneal Cavity; Phosphorylation; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-met; Pyrazines; Signal Transduction; Triazoles | 2015 |
Hapten synthesis for enzyme-linked immunoassay of the insecticide triazophos.
Topics: Animals; Antibodies, Monoclonal; Antibody Specificity; Ascites; Binding, Competitive; Enzyme-Linked Immunosorbent Assay; Haptens; Insecticides; Mice; Mice, Inbred BALB C; Organothiophosphates; Reference Standards; Triazoles | 2006 |
Influence of a platelet-activating factor antagonist on severe pancreatitis in two experimental models.
Topics: Animals; Ascites; Azepines; Male; Pancreatitis; Platelet Activating Factor; Rats; Rats, Wistar; Survival Rate; Triazoles | 1992 |
[Derivatives of dipheoro-acetic acid with antibacterial activity. 3].
Topics: Acetates; Amides; Animals; Anti-Bacterial Agents; Antineoplastic Agents; Ascites; Bacillus megaterium; Bacillus subtilis; Bacteria; Carcinoma, Ehrlich Tumor; Esters; Male; Mice; Naphthoquinones; Proteus; Pseudomonas; Sarcina; Staphylococcus; Triazoles | 1968 |